אורמד Stock: price and insider trades · Israel
אורמד: what insiders have been doing
אורמד is a listed company. Its insiders report their share dealings to TASE (ISA). The last twelve months, up to 18 October 2026, brought 10 filings signed by 9 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of אורמד for at least a year.
Compared with its exchange (530 companies, median 14 filings), a count of 10 filings is below the norm.
Source: insider filings from TASE (ISA). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 2,512,175 shares63.6% of flowShareXTAETASE:1691:13999:1141324:2026-06-30
- 120,300 shares100.0% of flowShareXTAETASE:1691:14139:1141324:2025-12-31
- 189,484 shares100.0% of flowShareXTAETASE:1691:12729:1141324:2026-03-26
- 103,109 shares100.0% of flowShareXTAETASE:1691:11815:1141324:2026-03-26
- 1,959,720 shares100.0% of flowShareXTAETASE:1691:13379:1141324:2026-03-26
- 2,047,652 shares36.4% of flowShareXTAETASE:1691:13999:1141324:2026-01-14
- 3,167,231 shares100.0% of flowShareXTAETASE:1691:13700:1141324:2025-12-31
- 41,430 shares100.0% of flowShareXTAETASE:1691:11272:1141324:2026-03-26
- 28,820 shares100.0% of flowShareXTAETASE:1691:13640:1141324:2026-03-26
- 2,895,487 shares100.0% of flowShareXTAETASE:1691:11196:1141324:2026-03-26
10 of 10 declarations
About אורמד
Oramed is a company focused on developing innovative treatments for diabetes, including oral solutions for insulin administration. It is listed on the XTAE.